Background {#Sec1}
==========

Islands of gastric mucosa in the proximal esophagus are commonly designated as inlet patches (IP). They are considered to be heterotopic in nature in that they represent remnants of the columnar lining of the fetal esophagus. Discussed sequelae of clinical significance are laryngitis, esophagitis, esophageal web, stricture, ulcer, perforation, fistula or adenocarcinoma \[[@CR1]\]. Severe sequelae are rare, reported only in individual case reports. More than fifty cases of adenocarcinoma arising from an IP have been reported between 1950 and 2016 (literature reviews \[[@CR2], [@CR3]\], recent case reports \[[@CR2], [@CR4]--[@CR12]\]). Some experts recommend to take biopsies from IP in order to detect neoplastic or preneoplastic alterations \[[@CR13]--[@CR15]\], or advise follow-up examinations \[[@CR15], [@CR16]\]. Before such recommendations can be generalized, more data on the prevalence of preneoplastic alterations in IP are needed.

Data on the very prevalence of IP diverge a lot. Prospective studies have yielded higher prevalences, ranging from 1 to 14% \[[@CR15], [@CR17]--[@CR33]\], than studies with retrospective design, 0.18 to 1.6% \[[@CR13], [@CR17], [@CR34]--[@CR41]\].

Preneoplastic conditions or lesions of IP are not yet defined. IP may contain any type of mucosa of the normal stomach, i.e. antrum, corpus or cardia mucosa, but also intestinal metaplasia \[[@CR15], [@CR19], [@CR21], [@CR26], [@CR27], [@CR31], [@CR35], [@CR38], [@CR39], [@CR41], [@CR42]\]. In the stomach, *Helicobacter pylori* infection, mucosal atrophy and intestinal metaplasia (Correa cascade) increase the risk of gastric adenocarcinoma \[[@CR43], [@CR44]\]. In the lower esophagus, Barrett's esophagus is an established preneoplasia. But there are differing definitions of Barrett's esophagus regarding the type of columnar metaplasia. The risk for esophageal adenocarcinoma is lower with pure gastric metaplasia than with intestinal metaplasia. Among others, American and German guidelines require the presence of intestinal metaplasia to define Barrett's esophagus \[[@CR45]--[@CR47]\]. Retrospective publications have indicated that there is an association between the presence of IP and that of Barrett's esophagus \[[@CR25], [@CR29], [@CR35], [@CR36], [@CR38], [@CR48]\] or even adenocarcinoma of the lower esophagus \[[@CR38], [@CR48]\].

The aims of the study were to determine the prevalence of IP in a prospective endoscopic study, to characterize the type of columnar epithelium within these IP, in particular with respect to preneoplastic conditions, and to investigate the association between IP and Barrett's esophagus.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

The study was based on patients referred for esophagogastroduodenoscopy (EGD) to the endoscopy unit of the University Magdeburg. Prior to starting the prospective study, the prevalence of IP was determined retrospectively. By searching the electronic files from January 1996 through January 2002, fifty patients with endoscopic description of IP were retrieved out of 9928 EGD, corresponding to a frequency of 0.5%.

The prospective study lasted from February to June 2002. It was approved by the Ethics Committee of our university and conformed to the provisions of the Declaration of Helsinki. Patients gave written informed consent. During the five months period, the prevalence of IP was determined in consecutive patients endoscopically examined by one investigator (UP). Of the 444 EGDs he performed the following were excluded: emergency cases (*n* = 31), percutaneous endoscopic gastrostomy (*n* = 5), patients after esophagus resection (*n* = 4), malignant tumor (*n* = 2) or severe esophagitis (*n* = 4) in the proximal part of the esophagus, repetitive endoscopies during the study period (*n* = 26). All other patients with consent (*n* = 372) were included, irrespective of the indication. For statistical analysis, indications were dichotomized into dominant reflux symptoms (*n* = 93) versus the remainder (*n* = 279). Outpatients were 175, inpatients 197.

Endoscopy {#Sec4}
---------

EGD was performed using routine video-endoscopes (GIF Q 145, Olympus Optical, Hamburg, Germany). An endoscopic diagnosis of IP was made when an island of salmon red velvety mucosa was identified in the proximal esophagus. The number of IP and the maximum diameter of the largest IP were documented. An attempt was made to take biopsies from IP for histological evaluation in any patient concerned, but contraindications against biopsies or technical difficulties in taking biopsies were respected and documented. Biopsies from gastric antrum and corpus were obtained according to the updated Sydney protocol \[[@CR49]\].

Any pathology revealed by EGD was documented, as was conscious sedation, mainly midazolam iv, partly in combination with pethidin iv. The quality of visualization of the esophageal mucosa was graded into a 3-point scale.

Any columnar epithelium extending more than 0.5 cm proximal to the esophago-gastric junction, be it in form of tongues, islands or circumferential areas, were documented as "columnar epithelium lined lower esophagus" (CLE) and, if not contraindicated, biopsied for histopathology according to guidelines on Barrett's esophagus \[[@CR50], [@CR51]\]. The length of CLE and the maximum diameter of IP were estimated using an open biopsy forceps, or, in cases with long segments, comparing the distance from the incisors.

Histopathology {#Sec5}
--------------

Histological slides were stained with hematoxilin-eosin and a modified Giemsa stain (2%) to detect *Helicobacter pylori* bacteria. In cases with doubtful *Helicobacter pylori* status, Warthin-Starry stain was used in addition. Detection of goblet cells led to diagnosis of intestinal metaplasia.

Categories of Barrett's esophagus {#Sec6}
---------------------------------

Based on the endoscopically determined length of CLE and the histopathological detection of columnar epithelium with or without intestinal metaplasia, four categories with different definitions of Barrett's esophagus were tested as independent variables: (1) CLE of at least 0.5 cm length, any columnar epithelium; (2) CLE of at least 3 cm length, any columnar epithelium; (3) CLE of at least 0.5 cm length, columnar epithelium with intestinal metaplasia, (4) CLE of at least 3 cm length, columnar epithelium with intestinal metaplasia.

Statistics {#Sec7}
----------

The expected prevalence of IP was estimated at 6%, based on the average of previous data of prospective studies in the literature. To achieve a width of 5% for the 95%-confidence interval of the proportion of patients with IP (prevalence), a sample size of *n* = 350 was calculated. The differences between the proportions of cases with and without IP in relation to different independent variables were statistically analyzed using non-parametric tests. Two-sided *P* values of less than 0.05 were considered to be statistically significant. The statistical software used was IBM SPSS Statistics 24™.

Results {#Sec8}
=======

Out of the 372 patients included, at least one IP was identified endoscopically in 54 cases (14.5%, 95% confidence interval 10.9%--18.1%). Demographic data are shown in Table [1](#Tab1){ref-type="table"}. More males than females had IPs detected (18 vs 11%), but the difference was not statistically significant. There was an insignificant trend for a higher prevalence of IP between 50 and 70 years of age compared to the prevalence in younger or older subjects (Fig. [1](#Fig1){ref-type="fig"}).Table 1Demographic data of patients with and without IPPatients with IPPatients without IPLevel of statistical significanceNumber*n* = 54*n* = 318Gender, number (percentage of columns)Chi square test *p* = 0.09 Female*n* = 21(39%)*n* = 163 (49%) Male*n* = 33 (61%)*n* = 155 (51%)Age (years)Mann-Whitney test *p* = 0.44 Minimum1918 Median5760 Maximum8993 Fig. 1Number of cases with and without inlet patch (IP) in relation to age categories

All IPs were located in the cervical part of the esophagus, mostly within 1 to 5 cm distal to the upper esophageal sphincter, but partly also at the level of the sphincter. Although the detection rate of IP increased with the grade of visualization, this correlation was not significant. There was no correlation with the use of conscious sedation.

A single IP was observed in 37 cases. In 17 patients there were multiple IPs; 2 of them in 9; 3 IPs in 5; and 5 to 7 IPs in 3 cases. The maximum diameter of the largest IP ranged from 0.2 to 4 cm (Fig. [2](#Fig2){ref-type="fig"}). A scatter diagram of the maximum diameter is shown in Fig. [3](#Fig3){ref-type="fig"}.Fig. 2Endoscopic view of a small inlet patch (*solid arrow*), estimated 0.3 cm in diameter, surrounded by subsquamous glands (*yellow spots*), including a cyst (*open arrow*) Fig. 3Scatter diagram of length of inlet patch (IP) in relation to length of columnar epithelium lined lower esophagus (CLE)

In 46 patients with visible IP, at least one biopsy could be targeted to the IP (1 biopsy in *n* = 7; 2 biopsies in *n* = 24; 3 in *n* = 14; and 5 in *n* = 1 patients). Reasons for not obtaining biopsies were uneasiness or retching in 6, and coagulation disorders in 2 patients. Columnar epithelium could be confirmed in *n* = 40 (87%) of these patients. Cardia- and corpus-type mucosa were found at an almost equal frequency (Table [2](#Tab2){ref-type="table"}). Biopsies from small IPs tended to contain more often cardia-type mucosa (Fig. [4](#Fig4){ref-type="fig"}), while those from larger IPs were more frequently composed of corpus mucosa. At the border between columnar and squamous cell epithelium, cardia-type mucosa was the predominant type of columnar mucosa (Fig. [5](#Fig5){ref-type="fig"}).Table 2Histology of IP in all patients with biopsy targeted to IP, and separately in two subgroups stratified according to maximum diameter of IP (percentages of columns)All patients with biopsy, *n* = 46Maximum diameter of IP\<1 cm, *n* = 24≥1 cm, *n* = 22Number (%)Number (%)Number (%)Cardia mucosa16 (35%)10 (42%)6 (27%)Cardia plus corpus mucosa12 (26%)7 (29%)5 (23%)Corpus mucosa12 (26%)4 (17%)8 (36%)Only squamous epithelium6 (13%)3 (12%)3 (14%) Fig. 4Histological view of a biopsy from a 0.5 cm inlet patch with predominating cardia-type glands. Moderate chronic and mild active inflammatory infiltrate associated with *Helicobacter pylori* infection (*inset*). Hematoxylin & eosin, original magnification ×100; Inset: Whartin Starry stain, original magnification ×1000 Fig. 5Histological view of a biopsy from a 12 mm inlet patch with transition of normal esophageal squamous epithelium (*left*) into gastric foveolar epithelium with cardia-type glands and deeper located corpus glands. Moderate chronic inflammation without *Helicobacter pylori* infection. Hematoxylin & eosin, original magnification ×100

There were 277 patients with a complete set of biopsies from the gastric antrum and corpus, and, if endoscopically detected, from IP. The prevalence of IP in this subgroup was *n* = 43 (15.5%) by endoscopy, and *n* = 36 (12.9%) confirmed by histopathology. In gastric biopsies, *Helicobacter pylori* bacteria were detected in *n* = 45 (16%). Five of these were found with an IP, but only one had *Helicobacter pylori* detected also in his IP (Fig. [4](#Fig4){ref-type="fig"}). Overall, mild chronic inflammation of IP was present in 37, moderate in 4 cases (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}). Active inflammatory infiltration of IP was always mild and occurred in 8 patients, including the one with *Helicobacter pylori*. The presence of chronic or active inflammation of IP was correlated neither with the presence of *Helicobacter pylori* infection of the stomach nor with any of the gastroesophageal reflux parameters mentioned below.Fig. 6Histological view of a biopsy from a 2.5 cm inlet patch with a combination of mucoid cardia-type and corpus-type glands and superficial focal intestinal metaplasia. Few subepithelial lymphocytes and plasma cells indicate a very mild chronic inflammatory reaction. Hematoxylin & eosin, original magnification ×100

Within IP, we observed intestinal metaplasia in two cases (Fig. [6](#Fig6){ref-type="fig"}). One 59-year-old patient had a single IP of 0.5 cm diameter, the other, aged 65 years, a single IP of 2.5 cm. Both were males with reflux symptoms, but without CLE. In both cases intestinal metaplasia was focal. Only the latter patient exhibited focal intestinal metaplasia also in the corpus.

The relationship between IP and parameters of gastroesophageal reflux are shown in Table [3](#Tab3){ref-type="table"}. Although the prevalence of IP was higher in patients with dominant reflux symptoms, hiatal hernia, reflux esophagitis, or Barrett's esophagus than in those without these respective conditions, these relations were not statistically significant. Only the higher prevalence of IP in patients with a CLE of at least 0.5 cm length and any columnar epithelium on histology was significant (*p* = 0.02, odds ratio 2.1). There was no significant correlation between the grade of reflux esophagitis and the presence of IP, nor between the length of CLE and the presence of IP, and nor between the length of CLE and the maximum diameter of IP (Fig. [3](#Fig3){ref-type="fig"}).Table 3Relation of the prevalence of IP with gastroesophageal reflux parameters and with different categories of Barrett's esophagusPrevalence of IP in the conditionPrevalence of the condition in patients with IPPrevalence of the condition in patients without IPLevel of statistical significance (Fisher's exact test, two-sided)Number (%)Number (%)Number (%)Dominant reflux symptoms15/93 (16%)15 (27%)78 (24%)*p* = 0.61Hiatal hernia13/83 (16%)13 (24%)70 (22%)*p* = 0.74Reflux esophagitis14/75 (19)%14 (26%)61 (19%)*p* = 0.25CLE ≥ 0.5 cm21/95 (22%)21 (39%)74 (23%)*p* = 0.02CLE ≥ 3 cm4/18 (22)%4 (7%)14 (4%)*p* = 0.31CLE ≥ 0.5 cm with IM7/30 (23%)7 (13%)23 (7%)*p* = 0.15CLE ≥ 3 cm with IM3/14 (21%)3 (6)%11 (4%)*p* = 0.44*CLE* columnar epithelium lined lower esophagus (endoscopic diagnosis)*IM* intestinal metaplasia (histopathologic diagnosis)

In the total study sample, the following pathological findings were documented in addition to those of Table [3](#Tab3){ref-type="table"}: esophageal thrush 3%, esophageal tumor 1%, esophageal varices 7%, esophageal peptic stenosis 1%, gastric ulcer 7%, gastric erosions 16%, gastric tumor 2%, previous distal gastric resection 2%, duodenal ulcer 2%, duodenal erosions 2%, duodenal stenosis 1%. None of these were significantly related to IP. A complete normal finding in the upper gastrointestinal tract was observed in 201 (54%) cases.

Discussion {#Sec9}
==========

The 14.5% prevalence of IPs revealed in this study is the highest ever reported as an English full text of a clinical study, to the best of our knowledge. But some studies report prevalences close to this, 10% by Borhan-Manesh et al. \[[@CR18]\], 11% by Weickert et al. \[[@CR27]\], 12% by Chung et al. \[[@CR30]\] using narrow band imaging, 13% by Vesper et al. \[[@CR33]\] and 14% by Kumagai et al. \[[@CR23]\]. In an abstract, Ohara et al. \[[@CR52]\] report even 21%, also using narrow band imaging. The same prevalence of 21% was yielded by an autopsy series of infants and children \[[@CR53]\]. In contrast, in the retrospective part of our study, the prevalence was low (0.5%), within the range of previously reported retrospective studies (0.18 to 1.6%) \[[@CR13], [@CR17], [@CR34]--[@CR41]\]. The discrepancy between retrospective and prospective studies is a clear indication that retrospective data comprise endoscopies in which IPs were often overlooked or neglected.

Nevertheless, IP should be looked for, and, if present, mentioned in examination reports. IP may give rise to benign or malignant sequelae, even though very rarely. Recent case reports on adenocarcinoma in IP include cases with small and flat lesions, fairly discernible from benign IP \[[@CR6], [@CR11]\]. Furthermore, IP should be distinguished from early esophageal squamous neoplasia, which also exhibits a flat red discoloration.

Like in the stomach and in Barrett's esophagus, intestinal metaplasia of IP may represent a preneoplastic condition. It has been described to occur in conjunction with an adenocarcinoma of IP \[[@CR10], [@CR54]--[@CR56]\]. However, there are no long-term data on the risk of neoplasia emerging from intestinal metaplasia of IP. In those 40 cases with histologically confirmed IP of our study, the prevalence of intestinal metaplasia was *n* = 2 (5%), admittedly a number too small to representatively estimate the proportion. This proportion is of similar magnitude as in other studies reporting intestinal metaplasia in IP, ranging from 0 to 12% \[[@CR15], [@CR19], [@CR21], [@CR26], [@CR27], [@CR31], [@CR35], [@CR38], [@CR39], [@CR41], [@CR42]\]. The two largest studies provided proportions of 1% \[[@CR38]\] respectively 3% \[[@CR39]\].

The high prevalence of IP in relation to the limited number of published cases with adenocarcinoma originating from IPs \[[@CR2]--[@CR12]\] challenges the recommendation given by some experts to obtain biopsies for histopathology from any IP \[[@CR13]--[@CR15]\]. Furthermore, taking biopsies in the proximal esophagus often provokes retching or coughing which makes it an uncomfortable or even risky approach. In our series, the low proportion of cases with intestinal metaplasia and the lack of any neoplasia within IP do not support such a recommendation. However, any irregularity of the mucosal surface of an IP identified on endoscopic examination should prompt taking targeted biopsies.

An high association of IP with Barrett's esophagus was reported in previous publications \[[@CR25], [@CR29], [@CR35], [@CR36], [@CR38], [@CR48]\], but not confirmed by other studies \[[@CR13], [@CR18], [@CR57]\]. We tested four different definitions of Barrett's esophagus for an association with IP. The reason is that in different guidelines there are conflicting definitions with respect to the histopathological verification of Barrett's esophagus. Some guidelines consider the presence of intestinal metaplasia as mandatory \[[@CR45]--[@CR47]\], whereas others require only columnar epithelium \[[@CR50], [@CR58]\]. Cardia-type mucosa in the lower esophagus has consistently been shown to be an acquired type of mucosa \[[@CR59]--[@CR61]\], and is likely to be a precursor of intestinal metaplasia \[[@CR62]\] and of adenocarcinoma as well \[[@CR63]\]. Therefore, we took into account also cases with endoscopically detected columnar lining in the lower esophagus ("CLE") that exhibited only cardia-type mucosa on histological evaluation, but no intestinal metaplasia. Only for this category of CLE, there was a significant association with IP.

One limitation of the study is that patients from a tertiary referral center were examined rather than a sample from the general population. Certainly, such patients are not representative of the general population, but currently there are no data to give consistent evidence that IPs might be significantly correlated with any other pathology, except for the relation with Barrett's esophagus.

Another limitation is the delay between the study and its publication. Advanced endoscopic modalities like high density resolution, near focus and virtual chromoendoscopy were not yet applicable, but might ameliorate the detection rate of IP. However, Vesper et al. \[[@CR33]\] found a high prevalence of IP (13.3%), which was comparable and not significantly different among standard definition videoendoscopy (12.7%), high definition endoscopy (14.4%), and narrow-band imaging (14.2%).

Endoscopic diagnosis of IP was confirmed by histopathology in 87%, which reduces the prevalence of IP to 12.6% as calculated for the whole study sample, or to 12.9% as counted in the subgroup of cases with a complete set of biopsies from stomach and esophagus. The most probable explanation for cases with endoscopic diagnosis of IP, but without histological confirmation, is unsuccessful targeting of the biopsy to a very small IP.

Half of our patients with IP had a maximum diameter of the largest IP of less than 1 cm (Table [2](#Tab2){ref-type="table"}). The small IPs were mostly composed of cardia-type mucosa, whereas the larger ones were more likely to contain corpus mucosa centrally. In the vicinity of IPs within squamous epithelium, one frequently observes yellow spots (Fig. [2](#Fig2){ref-type="fig"}). These were not taken into account as IP in our study. They contain foci of subsquamous columnar epithelium, addressed by some pathologists as esophageal glands proper. Noteworthy, these yellow spots resemble those in squamous epithelium close to the squamocolumnar junction of the esophagogastric junction \[[@CR64]\]. Esophageal submucosal glands are known to be clustered at either end of the esophagus \[[@CR65]\]. A convincing though unproven concept is, that such foci represent a precursor of columnar metaplasia of the esophagus \[[@CR66]\]. According to this concept, intraepithelial cysts erupt to the surface to build the columnar metaplasia. Our observation of very small IPs on the top of such yellow spots support the existence of such a dynamic process (Fig. [2](#Fig2){ref-type="fig"}).

Conclusions {#Sec10}
===========

The prevalence of IPs is often underestimated because IP may be overlooked or neglected. Regular biopsies for histopathology from any IP cannot be recommended because preneoplasia within IP is rare. Careful endoscopic inspection of IP, however, seems to be worthwhile in order to detect early malignancy and to differentiate IP from squamous cell neoplasia. The relation of IP with Barrett's esophagus, though clinically of minor relevance, may stimulate research on the common pathogenesis of IP and Barrett's esophagus.

Additional file {#Sec11}
===============

Additional file 1:Gastric Heterotopia datasets. Contains demographic, endoscopic and histological data, as mentioned at the head of columns. (XLSX 53 kb)
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